DR. BERTRAND Y TUAN M.D.
NPI 1578632980
Specialist in San Francisco, CA

Active since November 07, 2006PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
2100 WEBSTER ST STE 225, SAN FRANCISCO, CA 94115(415) 923-3012 Get Directions Write a Review

NPPES record last updated: July 8, 2007. Verified against the NPPES registry weekly; last sync: September 06, 2026.

About Dr. Bertrand Y Tuan M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. BERTRAND Y TUAN M.D. (NPI 1578632980) is an individual specialist in San Francisco, California, licensed in California (G78339) and active in the NPI registry since November 2006. He is enrolled in Medicare PECOS and is a graduate of Albert Einstein College Of Medicine Of Yeshiva University (1985).

NPPES Registry Identity

NPI1578632980
Entity TypeIndividualMale
Primary Taxonomy174400000X
Provider Legal NameDR. BERTRAND Y TUANCredential: M.D.
Location Address2100 WEBSTER ST STE 225San Francisco, CA 94115-2376
Mailing Address2100 Webster St Ste 225San Francisco, CA 94115-2376 · (415) 923-3012
Sole ProprietorNo
Medical School CMSAlbert Einstein College Of Medicine Of Yeshiva UniversityGraduated 1985
Enumeration DateNovember 7, 2006
Last NPPES UpdateJuly 8, 2007
NPI 1578632980 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtySpecialistOther Service Providers
Taxonomy Code174400000X
License Licensed in CA · G78339
Definition
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
2100 WEBSTER ST STE 225, San Francisco, CA 94115

Other Identifiers 3

MedicaidYYY49266YCA
Medicare UPINF31308CA
Medicare ID-Type Unspecified00G783390CA

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Bertrand Y Tuan M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9234298811
PECOS Enrollment IDI20081111000868
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 37

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, darbepoetin alfa, 1 microgram (non-esrd use) J0881
Darbepoetin alfa injection is a medication used to treat anemia (low red blood cell count) often caused by chronic kidney disease or chemotherapy. It works by stimulating your body to produce more red blood cells, helping to increase your energy and well-being.
17,043 services37 patients
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Q0138
Ferumoxytol injection is a treatment for iron deficiency anemia, a condition where your body lacks enough iron. It is injected into your vein to increase iron levels, aiding in the production of healthy red blood cells. This treatment is not for ESRD patients.
14,280 services16 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
8,780 services34 patients
Injection, pembrolizumab, 1 mg J9271
Pembrolizumab is a medication given via injection to help your body's immune system fight certain types of cancer. It's typically administered in a hospital or clinic by a healthcare professional.
7,300 services13 patients
Injection, daratumumab, 10 mg and hyaluronidase-fihj J9144
Daratumumab and hyaluronidase-fihj is an injection administered to treat certain types of blood cancer. The medication works by targeting and killing specific cancer cells. It's often given under the skin to reduce side effects and improve patient comfort.
4,871 services11 patients
Injection, fosaprepitant, 1 mg J1453
Fosaprepitant is an anti-nausea medication given via injection. It's often used to prevent nausea and vomiting caused by chemotherapy. This injection blocks signals to the brain that trigger these symptoms, helping you feel better.
2,407 services11 patients

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

100/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality91.46
Improvement Activities40

Reported Quality Measures

Care Plan
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker…
58%559 patients3/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
70%2,542 patients2/55-star benchmark: 100%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
84%330 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Pain Intensity Quantified
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified
99%418 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Plan of Care for Pain
Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain
98%121 patients4/55-star benchmark: 100%
Pain Assessment and Follow-Up
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present
98%2,542 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
61%953 patients3/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
79%571 patients4/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
24%792 patients2/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients screenedForUse: 90% · 554 patients
Patients tobacco: 88% · 554 patients
100%26 patients5/55-star benchmark: 98%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
43%953 patients2/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
0%953 patients1/55-star benchmark: 79%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Referred Medical Equipment & Supplies CMS DME claims 2

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Capecitabine, oral, 500 mg J8521
Treatment-Treatment - Miscellaneous · category RX029N
3 suppliers19 claims1,144 services$0.65 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period Q0511
Treatment-Chemotherapy · category RH012N
3 suppliers17 claims17 services$18.99 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 4

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Pharmacist
2100 WEBSTER ST STE 225
SAN FRANCISCO, CA 94115
Nurse Practitioner
2100 WEBSTER ST STE 225
SAN FRANCISCO, CA 94115
Internal Medicine (Hematology & Oncology)
2100 WEBSTER ST STE 225
SAN FRANCISCO, CA 94115
Specialist
2100 WEBSTER ST STE 225
SAN FRANCISCO, CA 94115

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Bertrand Tuan's NPI number?

The NPI number for Bertrand Tuan is 1578632980. It was assigned to this individual provider in the NPPES registry on November 7, 2006.

Where is Bertrand Tuan located?

Bertrand Tuan practices at 2100 Webster St Ste 225, San Francisco, CA 94115. The listed phone number is (415) 923-3012.

What is Bertrand Tuan's specialty?

The primary specialty registered for this NPI is Specialist with taxonomy code 174400000X.

Is Bertrand Tuan enrolled in Medicare?

Yes. Bertrand Tuan is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Bertrand Tuan was last updated on July 8, 2007. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 19 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.